News and Announcements
Colac Dairy Farmers Embrace ArcoFlex
- Published August 29, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Moving beyond pilots and trials, ArcoFlex has started to sell its silo monitoring solution to dairy farmers in the Colac region of Western Victoria. Every farm visited so far made an immediate purchase without having to be convinced. Whilst this is a small start, there are over 1,800 dairy farms in Western Victoria alone so this represents a significant commercial opportunity if this level of popularity holds up.
What has made ArcoFlex so appealing to these farmers is that it goes beyond just silo contents reordering. Most farmers also wanted their milk vat temperatures to be monitored. Running out of feed has productivity penalties but if the staff forget to turn the milk vat on, an entire day’s production can be lost. Until now, it has been very expensive hooking up different infrastructure to remote monitoring.
ArcoFlex Sensei’s flexibility helps solve multiple real world business problems with a single solution.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
